de Jeff Yass Edwards Lifesciences EW Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 5.16 M | Vender |
57,005
-62,414
| -52% | -USD 5.23 M | ﹤0.01% | 4554 |
|
|
2026
Q1 | USD 9.6 M | Vender |
119,419
-170,552
| -59% | -USD 14.1 M | ﹤0.01% | 3179 |
|
|
2025
Q4 | USD 24.7 M | Comprar |
289,971
+46,194
| +19% | +USD 3.79 M | ﹤0.01% | 2001 |
|
|
2025
Q3 | USD 19 M | Comprar |
243,777
+96,249
| +65% | +USD 7.52 M | ﹤0.01% | 2264 |
|
|
2025
Q2 | USD 11.5 M | Comprar |
147,528
+15,329
| +12% | +USD 1.14 M | ﹤0.01% | 2654 |
|
|
2025
Q1 | USD 9.6 M | Vender |
132,199
-168,936
| -56% | -USD 12.1 M | ﹤0.01% | 2589 |
|
|
2024
Q4 | USD 22.3 M | Comprar |
301,135
+194,761
| +183% | +USD 13.6 M | ﹤0.01% | 1767 |
|
|
2024
Q3 | USD 7.02 M | Vender |
106,374
-62,400
| -37% | -USD 4.53 M | ﹤0.01% | 3086 |
|
|
2024
Q2 | USD 15.6 M | Vender |
168,774
-3,954
| -2% | -USD 350 k | ﹤0.01% | 1995 |
|
|
2024
Q1 | USD 16.5 M | Vender |
172,728
-41,318
| -19% | -USD 3.47 M | ﹤0.01% | 2002 |
|
|
2023
Q4 | USD 16.3 M | Vender |
214,046
-71,839
| -25% | -USD 5 M | ﹤0.01% | 2020 |
|
|
2023
Q3 | USD 19.8 M | Comprar |
285,885
+23,177
| +9% | +USD 1.86 M | ﹤0.01% | 1755 |
|
|
2023
Q2 | USD 24.8 M | Vender |
262,708
-109,695
| -29% | -USD 9.5 M | 0.01% | 1524 |
|
|
2023
Q1 | USD 30.8 M | Comprar |
372,403
+116,362
| +45% | +USD 9.15 M | 0.01% | 1298 |
|
|
2022
Q4 | USD 19.1 M | Comprar |
256,041
+95,472
| +59% | +USD 7.36 M | ﹤0.01% | 1565 |
|
|
2022
Q3 | USD 13.3 M | Comprar |
160,569
+63,474
| +65% | +USD 6.11 M | ﹤0.01% | 1840 |
|
|
2022
Q2 | USD 9.23 M | Vender |
97,095
-131,000
| -57% | -USD 13.6 M | ﹤0.01% | 2310 |
|
|
2022
Q1 | USD 26.9 M | Comprar |
228,095
+86,726
| +61% | +USD 9.7 M | ﹤0.01% | 1431 |
|
|
2021
Q4 | USD 18.3 M | Comprar |
141,369
+27,275
| +24% | +USD 3.18 M | ﹤0.01% | 1952 |
|
|
2021
Q3 | USD 12.9 M | Vender |
114,094
-159,960
| -58% | -USD 18.3 M | ﹤0.01% | 2521 |
|
|
2021
Q2 | USD 28.4 M | Comprar |
274,054
+127,637
| +87% | +USD 12 M | ﹤0.01% | 1661 |
|
|
2021
Q1 | USD 12.2 M | Comprar |
146,417
+71,525
| +96% | +USD 6.05 M | ﹤0.01% | 2473 |
|
|
2020
Q4 | USD 6.83 M | Comprar |
74,892
+68,668
| +1,103% | +USD 5.7 M | ﹤0.01% | 2978 |
|
|
2020
Q3 | USD 497 k | Vender |
6,224
-9,335
| -60% | -USD 728 k | ﹤0.01% | 7695 |
|
|
2020
Q2 | USD 1.08 M | Vender |
15,559
-47,429
| -75% | -USD 3.37 M | ﹤0.01% | 5755 |
|
|
2020
Q1 | USD 3.96 M | Vender |
62,988
-196,017
| -76% | -USD 14.1 M | ﹤0.01% | 2878 |
|
|
2019
Q4 | USD 20.1 M | Comprar |
259,005
+254,037
| +5,113% | +USD 19.8 M | 0.01% | 1414 |
|
|
2019
Q3 | USD 364 k | Vender |
4,968
-60,657
| -92% | -USD 4.26 M | ﹤0.01% | 7907 |
|
|
2019
Q2 | USD 4.04 M | Comprar |
65,625
+45,342
| +224% | +USD 2.74 M | ﹤0.01% | 3008 |
|
|
2019
Q1 | USD 1.29 M | Comprar |
+20,283
| Nuevas | +USD 1.16 M | ﹤0.01% | 4507 |
|
|
2018
Q4 | – | Vender |
-22,350
| Cerradas | -USD 1.13 M | – | 9177 |
|
|
2018
Q3 | USD 1.3 M | Vender |
22,350
-81,117
| -78% | -USD 3.97 M | ﹤0.01% | 4743 |
|
|
2018
Q2 | USD 5.02 M | Vender |
103,467
-94,449
| -48% | -USD 4.41 M | ﹤0.01% | 2700 |
|
|
2018
Q1 | USD 9.2 M | Comprar |
197,916
+58,299
| +42% | +USD 2.53 M | ﹤0.01% | 1861 |
|
|
2017
Q4 | USD 5.24 M | Vender |
139,617
-90,696
| -39% | -USD 3.33 M | ﹤0.01% | 2494 |
|
|
2017
Q3 | USD 8.39 M | Comprar |
230,313
+223,767
| +3,418% | +USD 8.53 M | ﹤0.01% | 1935 |
|
|
2017
Q2 | USD 258 k | Vender |
6,546
-259,089
| -98% | -USD 9.46 M | ﹤0.01% | 7841 |
|
|
2017
Q1 | USD 8.33 M | Vender |
265,635
-196,158
| -42% | -USD 6.14 M | ﹤0.01% | 1799 |
|
|
2016
Q4 | USD 14.4 M | Comprar |
461,793
+358,332
| +346% | +USD 11.6 M | 0.01% | 1281 |
|
|
2016
Q3 | USD 4.16 M | Vender |
103,461
-412,128
| -80% | -USD 15.5 M | ﹤0.01% | 2466 |
|
|
2016
Q2 | USD 17.1 M | Comprar |
+515,589
| Nuevas | +USD 17.6 M | 0.01% | 1076 |
|
|
2016
Q1 | – | Vender |
-472,944
| Cerradas | -USD 13 M | – | 9161 |
|
|
2015
Q4 | USD 12.5 M | Vender |
472,944
-323,946
| -41% | -USD 8.41 M | 0.01% | 1553 |
|
|
2015
Q3 | USD 18.9 M | Vender |
796,890
-746,946
| -48% | -USD 18 M | 0.01% | 1253 |
|
|
2015
Q2 | USD 36.6 M | Comprar |
1,543,836
+80,562
| +6% | +USD 1.82 M | 0.02% | 868 |
|
|
2015
Q1 | USD 34.7 M | Comprar |
1,463,274
+758,898
| +108% | +USD 17 M | 0.02% | 839 |
|
|
2014
Q4 | USD 15 M | Comprar |
704,376
+14,604
| +2% | +USD 293 k | 0.01% | 1597 |
|
|
2014
Q3 | USD 11.7 M | Comprar |
689,772
+216,306
| +46% | +USD 3.41 M | ﹤0.01% | 1937 |
|
|
2014
Q2 | USD 6.77 M | Comprar |
473,466
+72,438
| +18% | +USD 982 k | ﹤0.01% | 2626 |
|
|
2014
Q1 | USD 4.96 M | Vender |
401,028
-3,021,810
| -88% | -USD 34.9 M | ﹤0.01% | 2909 |
|
|
2013
Q4 | USD 37.5 M | Comprar |
3,422,838
+2,671,392
| +356% | +USD 30.1 M | 0.02% | 841 |
|
|
2013
Q3 | USD 8.72 M | Comprar |
751,446
+162,282
| +28% | +USD 1.9 M | ﹤0.01% | 2040 |
|
|
2013
Q2 | USD 6.6 M | Comprar |
+589,164
| Nuevas | +USD 6.97 M | ﹤0.01% | 2264 |
|
Otros fondos que tienen EW en su cartera
Posición de Jeff Yass en EW: resumen de T2 2026
Jeff Yass redujo su participación en Edwards Lifesciences (EW) en 52% durante T2 2026, al vender acciones por un valor estimado de USD 5.23 M, y conservó 57,005 acciones valuadas en USD 5.16 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #4554.
Jeff Yass reportó por primera vez una posición en EW en T2 2013 y la ha mantenido durante 51 trimestres desde entonces. La posición alcanzó su máximo de USD 37.5 M en T4 2013. Al cierre de T2 2026, 1,341 fondos que sigue Wall St. Rank mantienen una posición en EW.
- Al cierre de T2 2026, Jeff Yass tenía 57,005 acciones de Edwards Lifesciences con un valor de USD 5.16 M.
- Jeff Yass vendió 62,414 acciones de Edwards Lifesciences en T2 2026, por un valor estimado de USD 5.23 M.
- Edwards Lifesciences representó ﹤0.01% de la cartera de Jeff Yass en T2 2026 y fue su posición número 4554.
- Jeff Yass reportó por primera vez una posición en Edwards Lifesciences en T2 2013 y la ha mantenido durante 51 trimestres desde entonces.
- La posición de Jeff Yass en Edwards Lifesciences alcanzó su máximo de USD 37.5 M en T4 2013.
- Al cierre de T2 2026, 1,341 fondos que sigue Wall St. Rank tenían Edwards Lifesciences en cartera.
Según el Informe 13F de Susquehanna International Group correspondiente a T2 2026, presentado el 14 ago 2026.